Cargando…
Utilization of Filgrastim and Infliximab Biosimilar Products in Medicare Part D, 2015-2019
This cross-sectional study examines utilization trends for filgrastim and infliximab products and their biosimilars to understand whether biosimilars are associated with reduced spending in Medicare Part D.
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902649/ https://www.ncbi.nlm.nih.gov/pubmed/35254434 http://dx.doi.org/10.1001/jamanetworkopen.2022.1117 |